Natural product-derived antiviral therapy against Neuroinvasive West Nile virus: Luteolin, a flavonoid found in Salvia tomentosa, Perilla, thyme, among others, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 8/April/2017, 11.38 pm

Molecular therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Lysophosphatidic acid (LPA), a phospholipid derivative that functions as a signalling molecule, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of its target gene, 8/April/2017, 10.50 pm
April 8, 2017
Natural product-derived regenerative therapy for reversing diabetes: Oleanolic acid, found in Syzygium S. or Jawa apple, and Prosopis glandulosa and among others, increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 9/April/2017, 6.51 pm
April 9, 2017
Show all

Introduction: What they say

A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA shows that “RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.” This research paper was published in the 30 March 2017 issue of the journal “Cell” [One of the best research journals in General biology with an I.F of 28.710] by Prof. Andrew Oberst, Brian P. Daniels and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived antiviral therapy against Neuroinvasive West Nile virus: Luteolin, a flavonoid found in Salvia tomentosa, Perilla, thyme, among others,  increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene


What is known?

Prof. Andrew Oberst’s research team has recently shown that mice deficient in Receptor-interacting protein kinase-3 (RIPK3): a) are highly susceptible to neuroinvasive West Nile virus (WNV); b) poorly induce chemokine expression in neurons; and c) poorly recruit T lymphocytes and inflammatory myeloid cells in central nervous system (CNS).


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, a natural product-based antiviral therapy against RNA viruses such as neuroinvasive West Nile virus (WNV).

Luteolin, by increasing the expression of its target gene, it may increase the expression of RIPK3 (Figure 1). Thereby, it may: (1) augment chemokine levels; (2) trigger neuroinflammation; (3) stall neuroinvasive West Nile virus replication; (4) promote clearance of neuroinvasive West Nile virus (WNV); and (5) strengthen antiviral immunity against RNA viruses.

Luteolin increases RIPK3 expression and inhibits neuroinvasive west nile virus production

Figure 1 Mechanistic insights into how Luteolin functions as an antiviral agent. Luteolin inhibits neuroinvasive West Nile virus (WNV) pathogenesis via up regulation of its target gene RIPK3

Thus, pharmacological formulations encompassing “Luteolin or its analogues either alone or in combination with any of the known antiviral compounds” may be used to treat infections caused by neuroinvasive West Nile virus (Figures 1-2 ).

luteolin க்கான பட முடிவு

Figure 2. The chemical structure of Luteolin


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Luteolin increase the expression of Receptor-interacting protein kinase-3 (RIPK3)?

Amount: $500#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., Natural product-derived antiviral therapy against Neuroinvasive West Nile virus: Luteolin, a flavonoid found in Salvia tomentosa, Perilla, thyme, among others, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 8/April/2017, 11.37 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.